C
Catarina Geraldes
Researcher at University of Coimbra
Publications - 50
Citations - 1485
Catarina Geraldes is an academic researcher from University of Coimbra. The author has contributed to research in topics: Medicine & Multiple myeloma. The author has an hindex of 13, co-authored 28 publications receiving 1173 citations. Previous affiliations of Catarina Geraldes include Hospitais da Universidade de Coimbra.
Papers
More filters
Journal ArticleDOI
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
Lotfi Benboubker,Meletios A. Dimopoulos,Angela Dispenzieri,John Catalano,Andrew Belch,Michele Cavo,Antonello Pinto,Katja Weisel,Heinz Ludwig,Nizar J. Bahlis,Anne Banos,Mourad Tiab,Michel Delforge,Jamie Cavenagh,Catarina Geraldes,Je-Jung Lee,Christine Chen,Albert Oriol,Javier de la Rubia,Lugui Qiu,Darrell White,Daniel Binder,Kenneth C. Anderson,Jean Paul Fermand,Philippe Moreau,Michel Attal,Robert Knight,Guang Chen,Jason Van Oostendorp,Christian Jacques,Annette Ervin-Haynes,Hervé Avet-Loiseau,Cyrille Hulin,Thierry Facon +33 more
TL;DR: Continuous lenalidomide-dexamethasone given until disease progression was associated with a significant improvement in progression-free survival, with an overall survival benefit at the interim analysis, among patients with newly diagnosed multiple myeloma who were ineligible for stem-cell transplantation.
Journal ArticleDOI
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Thierry Facon,Meletios A. Dimopoulos,Angela Dispenzieri,John Catalano,Andrew Belch,Michele Cavo,Antonello Pinto,Katja Weisel,Heinz Ludwig,Nizar J. Bahlis,Anne Banos,Mourad Tiab,Michel Delforge,Jamie D. Cavenagh,Catarina Geraldes,Je-Jung Lee,Christine Chen,Albert Oriol,Javier de la Rubia,Darrell White,Daniel Binder,Jin Lu,Kenneth C. Anderson,Philippe Moreau,Michel Attal,Aurore Perrot,Bertrand Arnulf,Lugui Qiu,Murielle Roussel,Eileen M Boyle,Salomon Manier,Mohamad Mohty,Hervé Avet-Loiseau,Xavier Leleu,Annette Ervin-Haynes,Guang Chen,Vanessa Houck,Lotfi Benboubker,Cyrille Hulin +38 more
TL;DR: Treatment with Rd continuous significantly improved survival outcomes vs MPT, supporting Rd continuous as a standard of care for patients with transplant-ineligible multiple myeloma.
Journal ArticleDOI
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: A position statement from the European Group for Blood and Marrow Transplantation
M. Mohty,Kai Hübel,N Kröger,Mahmoud Aljurf,J. F. Apperley,Grzegorz W. Basak,Ali Bazarbachi,K. Douglas,Ian H Gabriel,Laurent Garderet,Catarina Geraldes,Ozren Jakšić,Michael W. Kattan,Zdenek Koristek,Francesco Lanza,Roberto M. Lemoli,L. Mendeleeva,Gabor Mikala,N. Mikhailova,Arnon Nagler,Harry C. Schouten,D Selleslag,Stefan Suciu,Anna Sureda,Nina Worel,Patrick Wuchter,Christian Chabannon,R. F. Duarte +27 more
TL;DR: Determination of the CD34+ cell count in PB before apheresis helps to identify patients at risk of poor PBSC collection and allows pre-emptive intervention to rescue mobilisation in these patients.
Journal ArticleDOI
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Maria-Victoria Mateos,Shaji Kumar,Meletios A. Dimopoulos,Verónica González-Calle,Efstathios Kastritis,Roman Hájek,Carlos Fernández de Larrea,Gareth J. Morgan,Giampaolo Merlini,Hartmut Goldschmidt,Catarina Geraldes,Alessandro Gozzetti,Charalampia Kyriakou,Laurent Garderet,Markus Hansson,Elena Zamagni,Dorotea Fantl,Xavier Leleu,Byung Su Kim,Graça Esteves,Heinz Ludwig,Saad Z. Usmani,Chang-Ki Min,Ming Qi,Jon Ukropec,Brendan M. Weiss,S. Vincent Rajkumar,Brian G.M. Durie,Jesús F. San-Miguel +28 more
TL;DR: The 2/20/20 risk stratification model can be easily implemented to identify high-risk SMM for clinical research and routine practice and will be widely applicable.
Journal ArticleDOI
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization
Kai Hübel,Mm Fresen,J. F. Apperley,Gw Basak,Kw Douglas,Ih Gabriel,Catarina Geraldes,Ozren Jakšić,Zdenek Koristek,N Kröger,Francesco Lanza,Roberto M. Lemoli,Gabor Mikala,Dominik Selleslag,Nina Worel,Mohamad Mohty,Rafael F. Duarte +16 more
TL;DR: The data emphasize the role of plerixafor in poor mobilizers, but further strategies to improve the apheresis yield especially in patients with NHL are required.